Before PSM, statistically significant differences (p < 0.05) were found between the good and poor outcome groups for age, hypertension, dyslipidemia, smoking, history of stroke, RBC, WBC, NC, FIB, D‐dimer, HCY, CRP, baseline NIHSS score, In‐hospital mortality, 90D mortality and ≥3 arterial ischemic territories. This evidence concerns the gene CRP and metabolic syndrome.